Cathie Wood’s ARK Investment Management disclosed portfolio adjustments on Wednesday, August 26, 2026, reflecting a net shift toward semiconductor and AI-related holdings while reducing exposure to select software and biotech names.
The ARK ETF suite purchased 57,705 shares of Broadcom Inc. (NASDAQ: AVGO) for a total of $20.6 million, continuing a recent accumulation trend that included a similar purchase the prior week. The firm also added 69,585 shares of Cerebras Systems Inc. (CBRS) for $12.8 million and 47,794 shares of Cloudflare Inc. (NET) for $13.3 million. In the biotech sector, ARK acquired 304,851 shares of Generate Biomedicines Inc. (GENB) through the ARKG ETF for $6.2 million.
On the sell side, the ARK suite reduced its position in Advanced Micro Devices Inc. (NASDAQ: AMD) by 37,977 shares across four ETFs, totaling $18.2 million. The divestment followed an earlier sale earlier in the week, indicating a sustained reduction in exposure to the chipmaker. ARK also sold 181,919 shares of Tempus AI Inc. (TEM) for $12.5 million, 53,280 shares of Twist Bioscience Corp. (TWST) for $8.1 million, and 14,339 shares of CrowdStrike Holdings Inc. (CRWD) for $2.7 million. Smaller positions were trimmed in Robinhood Markets Inc. (HOOD), Roblox Corp. (RBLX), and Brera Holdings PLC (SLMT), with respective sales totaling $2.8 million, $585,430, and $105,500.
The trades reflect ARK’s ongoing strategy of reallocating capital toward high-conviction positions in AI infrastructure and semiconductor supply chains, while paring back exposure to software and speculative biotech names amid evolving market conditions.
